

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | The MET receptor tyrosine kinase (RTK) plays a central role in regulating cell growth, survival, and invasion. Binding of hepatocyte growth factor (HGF) promotes MET dimerization, stimulating MET kinase activity. AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the MET receptor. It potently inhibits the enzymatic activity of WT MET (IC50 = 1 nM) and a subset of MET mutants found in papillary renal cell carcinoma. AMG 337 also inhibits cell based HGF-induced MET phosphorylation in PC3 cells (IC50 = 5 nM). Competitive binding assays illustrated the selectivity of AMG 337, binding only MET when profiled against a diverse panel of 402 human kinases. AMG 337 inhibits proliferation in MET-dependent cancer cell lines following 72 hours of treatment with AMG 337. MET phosphorylation was completely inhibited in the gastric cancer cells lines MKN-45, SNU-620, and SNU-5 cells, following a 2-hour treatment with 100 nM AMG 337. In MKN-45 cells, 300 nM AMG 337 treatment for 24 hours resulted in a dose-dependent increase in cells in the G1 phase; with concurrent reduction of cells in S-phase. AMG 337 at a 0.5 mg/kg dose robustly inhibited Gab-1 (a kind of adaptor protein) phosphorylation, and escalation to 0.75 mg/kg or more resulted in >90% inhibition of MET signaling in the TPR-MET mouse tumor model [3]. |
| 作用机制 | AMG 337 binds to a well-defined, inactive conformation of the MET activation loop (A-loop) in a binding mode . |
| Concentration | Treated Time | Description | References | |
| Madin-Darby Canine Kidney II (MDCK) cells | 0.001, 0.01, 0.03, 0.1, 0.3, 1, 3, and 10 µM | 2 hours | To determine the inhibitory effect of AMG 337 on adenosine uptake in dog MDCK cells. Results showed an IC50 of 0.17 μM. | Transl Oncol. 2019 Oct;12(10):1296-1304. |
| Administration | Dosage | Frequency | Description | References | ||
| Beagle dogs | Conscious freely moving dogs | Oral | 30 mg/kg | For 10 consecutive days | To evaluate the effects of AMG 337 on hemodynamic function in dogs. Results showed AMG 337 caused decreases in blood pressure and increases in heart rate. | Transl Oncol. 2019 Oct;12(10):1296-1304. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.16mL 0.43mL 0.22mL |
10.79mL 2.16mL 1.08mL |
21.58mL 4.32mL 2.16mL |
|
| CAS号 | 1173699-31-4 |
| 分子式 | C23H22FN7O3 |
| 分子量 | 463.46 |
| SMILES Code | O=C1C2=C(N=CC(OCCOC)=C2)C=CN1[C@@H](C3=NN=C4C(F)=CC(C5=CN(C)N=C5)=CN43)C |
| MDL No. | MFCD29472283 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | DWHXUGDWKAIASB-CQSZACIVSA-N |
| Pubchem ID | 44181686 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(226.55 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1